Why Was Monte Rosa Therapeutics (GLUE) Stock Down on Oct 1, 2026?
GLUE fell 6.84% in the 10 minutes after the headline, $13.60 to $12.67.
- GLUE fell 6.84% over 10 minutes, $13.60 to $12.67.
- Headline time 07:00:00 ET on October 1, 2026.
- Volume 48.2K shares in 10 min.
07:00:00 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| GLUE | 13.60 | 13.60 | 13.71 | 12.67 | +0.81% | -6.84% |
Monte Rosa Therapeutics (GLUE) fell 6.84% in the 10 minutes after this headline reached the MoveSurge tape at 07:00:00 ET on October 1, 2026: “Monte Rosa Therapeutics reported that MRT-8102 effectively normalized key pathogenic factors of atherosclerotic cardiovascular disease in obese patients at high cardiovascular risk during the GFORCE-1 Phase 1 study.”
The reference price just before the headline was $13.60; 10 minutes later the stock traded at $12.67. One minute in it was $13.71, a +0.81% move. By 10 minutes it had reversed to -6.84%.
Traded size over the same window: Volume 48.2K shares in 10 min.
How this move was measured
MoveSurge prices an eligible headline against its own clock rather than against the close. A reference level is taken from just before the headline reaches the tape, and the same instrument is sampled again one minute and 10 minutes later. The four figures in the table below are those samples. They describe GLUE over 10 minutes, not over the trading day.
How far did Monte Rosa Therapeutics (GLUE) move after the headline?
From $13.60 just before the headline to $12.67 10 minutes later, a -6.84% move.
What crossed the tape on October 1, 2026?
At 07:00:00 ET: Monte Rosa Therapeutics reported that MRT-8102 effectively normalized key pathogenic factors of atherosclerotic cardiovascular disease in obese patients at high cardiovascular risk during the GFORCE-1 Phase 1 study.
Is the 6.84% figure a whole-day move?
No. It covers the 10 minutes after the headline reached the tape, measured from a reference price taken just before it.
Sources
-
GLUE on the MoveSurge tape, Oct 1, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes recorded price reactions, search, watchlists, alerts and research tools.
Create free accountGo real time Watch live headlines -- free